Digital Health and Healthcare Quality: A Primer on the Evolving 4th Industrial Revolution by Otokiti, Ahmed Umar
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







Digital Health and Healthcare 




The inefficiencies of the healthcare sector continue to be a barrier to achieving the 
quadruple aim of healthcare quality improvement. The 4th Industrial Revolution 
has been characterized by rapid transformations due to information technology, 
data volume, ubiquity, and increased computer processing power. Despite all 
the promises and hopes of Digital health tools as a means of attaining healthcare 
quality, there remains many challenges and hurdles to overcome. This chapter 
describes the relationship between the 4th Industrial Revolution and healthcare 
quality as it relates to its impact on healthcare quality, applications, and chal-
lenges. Suggestions to stakeholders on ways of navigating these challenges are also 
discussed.
Keywords: digital health, health information technology, 4th industrial revolution, 
healthcare quality improvement, quadruple aim, artificial intelligence, ML, 
data science, patient safety
1. Introduction
1.1 Basic concepts of digital health and big data
1.1.1 Differentiating digital health from health informatics and E-health
Digital Health (DH) is an evolving multidisciplinary scientific field that seeks to 
monitor medical problems while also preventing new ones with the ultimate aim of 
improving the overall quality of health. [1, 2] These means of information technology 
can be applied through mobile health (mHealth), telehealth/telemedicine, activity 
trackers, personal wearables, and remote monitoring, and represent an interplay of 
the art and science of medicine to achieve overall improvement in health. [2] Due 
to its broad nature, DH is usually used interchangeably with health information 
technology (HIT).
Electronic-health or E-Health is characterized by an intersection of public 
health, medical informatics, the business of healthcare, information science, and 
health services to achieve better health for users. [3] The term comprises both tech-
nical aspects like hardware, software, and internet broadband and social elements 
centered on the way of thinking and networked global effect through information 
technology. [3]
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1.1.2 Sources of big data and its contemporary drivers in healthcare
Big data refers to an enormous data set existing as either structured (organized), 
unstructured (unorganized), or mixed. [4, 5] These characteristics have been 
described as the paradigm of 4 “Vs:” volume, velocity, variety, and veracity. [4, 6–8] 
Generally, about 2.5 quintillion bytes of data are created every day worldwide and it 
is rather amazing that 90% of it was created in the past 5 years. [9]
Sources of big data span a wide spectrum including posts from social media 
sites to sensors and navigation devices. It is a big challenge to determine the 
amount of data generated yearly by the healthcare industry due to the complex 
nature of healthcare data with heterogeneous sources and structures. [10] 
Healthcare data sources include electronic health record data (EHR), prescription 
compliance and refill rate, personal activity tracking devices, laboratory data, 
cell phone-based geographical monitoring, and remote telemedicine monitoring. 
About 500 petabytes of data were generated by electronic medical records alone 
in 2012 and it is expected to reach 25,000 petabytes by the end of 2020. [11] The 
various methods/processes of big data analysis are referred to as analytics.
Many factors are responsible for our contemporary adoption and application 
of big data and DH. The greatest driving force is the dynamic state of computer 
power relative to it cost of acquisition rightly predicted by Moore’s law. It states 
that computer power (in terms of speed and memory storage) will double every 
two years at the same price. In 1956, you would have had to pay $10 million for one 
gigabyte of storage. In 1981, the cost of a gigabyte was $ 300,000 and by the year 
2000, it had dropped to $10. In 2010, the price of storing a gigabyte of data dropped 
to just 10¢. [12]
Another technology-based driver is the advent of cloud computing. This is 
the process of utilizing remote computer networks via the internet to manage, 
process, store, and manipulate data rather than utilizing the local or personal 
computer connected to the network. This phenomenon allowed for an exponential 
increase in the capacity of local computers, hence serving as a driver for the 
“internet of things,” or the interconnectivity between various devices embedded 
with electronics, software, and sensors. Its ability to impact all major players in 
the healthcare industry, including the patient, healthcare provider, healthcare 
regulators, payers, and vendors, has been described as the Internet of Medical 
Things (IoMT). [13]
Another driver of big data application and DH is the advancement in genomic 
medicine and gene therapy. [13] Gene mapping and sequencing is an integral part 
of big data as it utilizes various bioinformatics processes for interpretation and 
storage.
The most important factor remains the paradigm shift in the role of the patient 
as a “consumer” of health services. Patients seek to better manage their health by 
playing active roles through information gathering on the internet and especially via 
social media networks. [14] One in three Americans has gone online to investigate a 
medical condition. [15] Another important factor is the changing demographics of 
the aging population and prevalence of chronic diseases leading to escalating cost of 
healthcare. In fact, the cost of chronic diseases accounts for up to 75% of healthcare 
cost in the US. [16]
DH innovations have shown some promising results as a means of achieving 
efficient and cost effective care without compromising quality of care. [17] The 
mandate from regulators to shift from a volume- to value-based reimbursement 
model is a testament to the fact that the shift to reward quality, efficiency, and col-
laborative care is here to stay. [18] The incentive for hospitals to adopt meaningful 
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use of digital technology due to the Health Information Technology for Economic 
and Clinical Health (HITECH) act, enacted as part of the American Recovery and 
Reinvestment Act of 2009 [19], resulted in widespread adoption of electronic health 
records system in the US.
1.2  Practical applications of data science in DH: traditional techniques, artificial 
intelligence, and machine learning
Data is the foundation of DH. Data science is the term used to describe the 
scientific study of the creation, validation, and transformation of data to create 
meaning. [20] It is composed of multiple disciplines like statistics, mathematics, 
and computer science (Figure 1). Data science is an overarching field that underlies 
many DH innovations like artificial intelligence (AI), machine learning (ML), deep 
learning, reinforcement learning, and data mining (Figure 2). [21]
ML is a sub-discipline of AI that uses algorithms to identify patterns in data, as 
such giving computers the ability to learn without being explicitly programmed to 
create predictive models based on training data and validated on test data.
Data mining refers to the discovery of patterns in large data sets with methods 
at the intersection of unsupervised learning, traditional statistics, and database 
systems. [22] Predictive analytics involves learning from historic data to predict 
likely future outcomes with an expressed degree of certainty. Clinical decision sup-
port (CDS) programs are systems set up to augment clinicians in their day-to-day 
complex decision-making processes. [23]
Figure 1. 
Data science as a multidisciplinary field of study. Diagram reprinted with permission from Robert (Bob) Hoyt, 
MD, FACP, FAMIA, ABPM-CI.
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1.3 DH’s relationship with the healthcare value equation
All the factors driving DH and HIT are geared towards a paradigm shift from our 
present state of “sick care” to “high value healthcare.” [24] Healthcare value defini-
tion is rather challenging because of its complex ecosystem with many different 
stakeholders and their associated conflicting goals and expectations. [25]
Nevertheless, the meaning which most stakeholders can relate to is the concept 
of value in healthcare as outcome (rate of quality outcome) per cost needed to 
achieve a result. [26] It is represented mathematically as quality/cost and is the 
extent to which our health interventions achieve desired health outcomes that are 
consistent with evidence-based knowledge. [27] Essentially, it is healthcare which 
is cost effective and efficient, safe, patient-centered, and equitable, with the aim of 
achieving the best outcome in terms of morbidity and mortality. [28, 29]
Patient safety on the other hand is the foundation of quality care. The Institute 
of Medicine (IOM) believes that health quality is indistinguishable from Patient 
safety. [30, 31] I will define patient safety as a system of care delivery that prevents 
errors built on a culture that learns from previous mistakes. In simple terms, it is a 
system that functions to avoid harm to patients. [32] And healthcare quality will be 
analyzed in the context of the quadruple aim of quality improvement. [33]
The quadruple aim is a compass to optimizing health system performance which 
is made up of four components: improving health outcome and experience of care, 
improving population health, improving healthcare cost, and improving staff 
engagement.
To overcome the inefficiencies of the healthcare sector in the US, healthcare 
organizations are encouraged to adopt methodologies like the lean or six sigma 
methodology that has a track record of optimizing systems in other sectors. Lean 
methodology involves processes put in place to reduce waste in every procedure, 
process, and task based on an ongoing system of improvement and learning, 
and focuses on eliminating waste by avoiding efforts that do not add value to the 
Figure 2. 
Relationship between data science, artificial intelligence, and machine learning. Diagram reprinted with 
permission from Robert (Bob) Hoyt, MD, FACP, FAMIA, ABPM-CI.
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patient. [34] Six sigma, on the other hand, is a metric-driven system used to reduce 
medical errors, defects, and variations in output by applying the following: design, 
measure, analyze, improve, and control (DMAIC). [35]
Examples of successful applications include reducing time to life saving pro-
cedure like door-to-balloon time in cardiac catherization, unnecessary antibiotics 
prescriptions, turnaround time for pathology reports, and clinic wait times, and 
streamlining electronic payment for vendors. [35, 36] Optimized symptoms that 
run efficiently can maximize the output of DH technologies. [37]
The US spends up to 17.6% of its GDP on healthcare which is far more than 
that of all the other developed nations combined at 9%. Despite this amount of 
spending, the US ranks poorly in the World Health Organization’s ranking of health 
system performance. [38] The public health improvement goals of the quadruple 
aim correspond with the goal of contemporary medicine which involves the need 
to achieve cost-efficient quality health through participatory and personalized 
medicine, ultimately ensuring optimum predictive and preventive medicine. [37]
The last component of the quadruple aim is provider satisfaction and engage-
ment. Healthcare quality can hardly be achieved without an engaged healthcare 
workforce. Burnout involves a state of emotional exhaustion (with or without 
physical fatigue) and powerlessness to change the status quo. [39–41] Up to 60% 
of healthcare providers experience one or more symptoms of burnout in the US 
[42, 43] and suicide rate amongst physicians in the US is higher than those of the 
general population. [39] Multiple factors are responsible for burnout which include 
high data and information volumes and changes in the healthcare model including 
a shift from volume- to value-based care. [40]
Even cutting-edge EHR functionalities involving AI/ML for predictive clinical 
decision support are potential sources for provider dissatisfaction and burnout 
due to lack of regulation mandated user-centered design approach in their product 
development. [44, 45]
1.4 The 4th industrial revolution and its peculiarities
The 4th Industrial Revolution is philosophical and ideological construct by the 
world economic forum which postulates on how digital, physical, and biological 
technology have uniquely combined together in our contemporary world creating 
new opportunities and challenges. [41]
The first Industrial Revolution was powered by steam in the 18th century, the 
2nd powered by electricity in the 19th century, and the 3rd in the 20th century 
powered by technology. [46] Although the 4th Industrial Revolution is considered 
by many as a direct extension of the 3rd, the 4th differs due to the unprecedented 
volume and velocity of data in addition to enhanced global interconnectivity. [47]
To reap the potential benefits in the 4th Industrial Revolution, it is imperative 
for the healthcare sector to adopt practices like the agile methodology with the 
ability to “fail fast” while learning quickly in an iterative manner to achieve the 
desired state of healthcare quality. [48]
1.5 Literature research strategy
The peer reviewed articles reviewed for this chapter were obtained from a broad 
literature search performed in PubMed, and Google scholar. Search terms included; 
“4th industrial revolution”, “digital health” “quality improvement”, “Digital health 
and patient safety”, “applications of digital health for healthcare quality”, “Digital 
health security”, “Regulation of digital health”. Due to the relative novelty of digital 
health and the 4th industrial revolution, other sources of relevant information like 
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digital health magazines, quality improvement magazines and health informatics 
websites were also refer referenced.
2.  Contemporary applications of HIT and DH In the context of 
healthcare quality improvement
The full potential of DH remains unquantifiable at this juncture mainly because 
of a shortage of well-conducted evaluation studies showing evidence of value added 
by new tools, especially those involving AI/ML. [49, 50] The rapid acceleration of 
DH methods and overall geometric advancement is such that any novel technology 
is almost outdated upon arrival. Despite all these setbacks in the application of 
DH, there have been some notable applications which have shown some promising 
results.
2.1 Individual healthcare maintenance
Remote patient monitoring involves patient data collection by appropriate 
providers with data either patient reported or automatically collected via apps, 
sensors, and any other specific gadget (glucose meters, blood pressure cuffs, or 
scales). This produces a vast amount of real-time data which is usually beyond 
the analytic capacity of the healthcare provider, creating an excellent scenario for 
predictive analysis of the data using ML and similar tools. [51, 52]
ML analysis of bidirectional remote monitoring and EHR data has potential to 
provide great insights on the overall quality of individual patient care. [51] Remote 
monitoring has successfully been applied to diseases like congestive heart failure 
management (resulting in a 30% reduction in admission) [44] and diabetes man-
agement (resulting in better glycemic control compared to standard of care). [53]
2.2 Direct patient care and patient safety
Utilizing standardized risk scores and predictive analysis, some organizations 
have been able to predict patients that are likely to be readmitted to the hospital 
within 30 days after discharge. [54] Apart from the mortality benefits to the 
patients, the institution is also able to benefit financially as they avoid significant 
penalties associated with readmissions imposed by Medicare under the Medicare’s 
Hospital Readmissions Reduction Program (HRRP). [55]
Algorithms that predict the likelihood of hospitalized patients to develop acute 
kidney injury during their index hospital stay have been successfully developed 
as well. [56] Additionally, significant reduction in sepsis mortality by algorithms 
leveraging the patient’s data in the EHR to predict severe sepsis have also been 
achieved. [57]
An algorithm developed using EHR data was able to predict suicide risk in 
individuals better than traditional clinical methods. [45] Predictive analytics tools 
continue to demonstrate their role in the overall reduction of in-hospital adverse 
events. [58]
The use of CDS in antibiotics choice has been shown to significantly increase 
antibacterial susceptibility, thereby reducing the need for broad-spectrum antibac-
terial agents and the risk of antibiotic resistance. [59]
Considering the complexity of cancers, the vast amount of knowledge released 
daily, and expansion of treatment options, the incorporation of genomic data in 
treatment modality all make it very challenging for clinical oncologist to choose the 
best personalized therapy. [47] CDS in oncology have shown some potential with 
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assisting clinicians to navigate the challenges inherent in treatment modalities and 
have performed similar to multidisciplinary tumor boards. [60]
The risk of failure in predictive analytics and CDS can result in significant 
patient harm, hence why mitigation of risk and human oversight is still an essential 
part of their deployment.
2.3 Healthcare operations: payment, billing, and scheduling
Predictive analytics have been used to accurately identify patients likely to skip 
appointments without advanced notice. [61] Additionally, they have been successfully 
used to anticipate peak and low utilization periods by mining previous utilization data. 
[62] This knowledge assists leadership in planning for changes in volume so they are 
ready with corresponding resources required to navigate changes in volume. Other 
proven applications of AI/ML include automation of invoice processing, correct coding 
for reimbursement, and processing of insurance denials and claims. [51]
2.4 Public health essentials
The optimal state of public health of a nation should emphasize predictive and 
preventive care in addition to easy and equitable access to healthcare to improve 
overall mortality and morbidity. While the US health system falls short of these 
public health essentials in comparison to other developed nations, DH application 
has shown some promising outcomes. [57]
2.5 Predictive and preventive medicine
Individual risk for developing chronic disease can be ascertained with a high 
degree of certainty. Integrative genetic profile has been applied successfully to 
determine high risk of diabetes mellitus type 2 in an individual who did not have 
common risk factors like obesity and family history. [63]
Direct-to-consumer genetic testing for risk factors of diseases are also gaining  
traction with commercialized proteomic analysis testing kit for diseases like 
Alzheimer’s disease. [53] Utilizing proteomic analysis of specific blood proteins was 
able to a determine if a lung nodule was benign with 90 percent accuracy during 
screening. [64]
Similar DH based programs can assist with opioid epidemics as they have been 
proven to result in a 30% reduction in statewide opioid prescriptions. [65–67] 
Another promising application involves the development of opioid abuse risk 
profiles of patients using ML model and EHR data to predict patients who are prone 
to future abuse and overdosage. [68]
2.6 Improving health access
The healthcare provider shortage coupled with the increasing aging population 
are factors that exacerbate healthcare access and inequity across the nation. [54] 
This shortage of healthcare providers and lack of access to health is worse in rural 
areas where 65% of non-metropolitan counties lack psychiatrists and 45% are 
without psychotherapists. [55] Telemedicine has shown strong evidence as a means 
of increasing access to mental healthcare in rural areas by providing effective treat-
ment for mental health conditions, improving medication adherence, and effective 
follow up and continuity of care. [69] AI-powered chat bots can be used for initial 
triage based on symptoms and an expert engine can determine type and nature of 
visit necessary (either a virtual check-in or a face-to-face visit).
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2.7 Regulations and oversight
The US Government’s 21st Century Cure Act prioritized improvement in HIT, 
including interoperability, patient access to their health records, and improved 
regulatory oversight for DH. [56] As part of the Cures Act, the Food and Drug 
Administration (FDA) Center for Drug Evaluation and Research (CDER) has 
adopted analytics methodologies like “in silico” testing. This is particularly impor-
tant in diseases where the smaller patient sample sizes is often a limitation of their 
clinical trials. [70]
3.  Not all that glitters is gold: challenges and shortcomings of HIT and 
DH utilization to achieve the quadruple aim of quality improvement
Despite the excitement which comes from the potential of DH for quality 
improvement, challenges exist. Not considering these challenges is akin to chasing 
“shiny objects” with potential for negative and adverse consequences both in the 
short and long term.
3.1 Overall HIT challenges across DH and big data
3.1.1 Lack of interoperability
Interoperability is the ability of different information systems to access, 
exchange, and cooperatively use data in a coordinated manner, within and across 
organizational and regional boundaries, to provide timely and seamless portability 
of information for optimal healthcare. [57] The healthcare data ecosystem in the 
US is highly fragmented with different EHR systems as a repository of patient data. 
These disparate EHR systems are not connected and as such their lack of interoper-
ability is a huge set back and operational burden to DH implementation for patient 
safety.
3.1.2 Lack of consensus standard for evaluation and monitoring
The lack of consensus evaluation standards in DH is also a barrier to determin-
ing the value added. [71] The world of biomedical sciences is accustomed to the tra-
ditional randomized control trials as a gold standard for evaluation. Unfortunately, 
this is not always a practical option for most DH applications due to variation in 
input data and a lack of stability of deliverables needed to quantify outcomes in 
RCT. [72] Although various evaluation framework exists across the industry, no 
consensus standards have been generally accepted across board. [73] Thus, we have 
no standardized method of determining the effectiveness of the over 300,000 
medical apps available. [71]
3.1.3 Lack of emphasis on DH/hit in the context of the socio-technical impact
Most stakeholders consider DH a singular fix for the inefficiencies in healthcare. 
[74] But, for any DH innovation to be successful, design and implementation need 
to be compatible with all elements of the system engineering initiative for patient 
safety (SEIPS) model. [75] The elements to consider in this model include consid-
eration of persons involved and their peculiarities, available technology and tools 
for success, organizational culture, type of tasks, environmental layout, care and 
information process/flow, and patient outcomes.
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This lack of overall socio-technical consideration manifests as the absence of 
stakeholder input in the development of new DH tools, consequently leading to 
poor usability of the DH tool like the EHR, which is a significant contributor to 
provider burnout and inefficiency. [76] Additionally, the low usability of EHR 
increases the cognitive load of the healthcare provider, which contributes signifi-
cantly to medical error. [77]
Lack of overall consideration in the context of the socio-technical landscape 
increases the chances of unexpected consequences like creating workarounds in the 
EHR with a negative impact on patient safety. [78]
3.1.4  Regulatory bodies and government unable to keep up with the dynamic 
changes brought on by DH
Government and regulatory agencies struggle to provide a clear-cut regula-
tory pathway for DH tools. Restrictions and barriers to telemedicine adoption like 
provider portability of license to practice across state lines, geographical restrictions, 
and specifics about reimbursement parity still exist and have only been temporarily 
lifted during the 2019–2020 COVID-19 pandemic. [79] The lack of consistent regula-
tions of proliferating medical apps prevents a high risk to patient safety. [80]
3.2 Expectations and value gaps
Innovations in most healthcare organizations in the US are driven by the need 
to meet basic regulatory compliance metrics and financial viability (bottom line). 
Healthcare leadership are more concerned about the bottom line while regulators 
are mostly concerned about patient safety. Patients are concerned about conve-
nience of service and safety.
3.3 Data security and data integrity
Another important issue with DH and big data is the constant threat to health-
care data integrity and security. These occur in the form of hacking, malware, 
unauthorized access, and data theft. In 2019, almost 41 million medical records 
were affected by healthcare data breaches, mostly through hacking and ransomware 
attacks. [81] The average cost of these breaches to affected healthcare organizations 
was about $6.5million. [82]
3.4 Disparity in access to DH tools
Presently, resources (infrastructure, expertise, and personnel) required to 
utilize DH/big data are not available to all and confer a competitive advantage to 
those who possess them. The resulting disparity and its consequences are contrary 
to the outcome we seek from DH innovations. Nearly half of the world’s population 
do not have reliable internet access. This phenomenon is well known and described 
in the literature as the “digital divide.” [64].
3.5 Challenges peculiar to artificial intelligence and ML
3.5.1 Lack of explainability and interpretability
Explainability describes the degree of transparency and traceability of the 
outcome of any AI/ML model. [83] This is particularly important because of 
the non-linear, highly nested structure of complex algorithms, which makes us 
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unaware of how they arrive at their conclusion or output. [65] This characteristic, 
described as the “black box” phenomenon, represents a huge setback in the 
application of AI/ML in healthcare. [66] This is mainly due to the sensitive nature 
of health operations and its low tolerance for lack of transparency in decision 
making. Thus, those who develop AI tools must involve primary stakeholders and 
decision makers from the beginning to assist with transparency and adoption by 
end users.
3.5.2 Highly dependent on data quality and quantity
Predictive analytics and model development rely heavily on not just high volume 
data but also high quality data. Unfortunately, most available healthcare data are 
unstructured and interspersed with artifacts/“noise” which increases the chances of 
spurious model output even in the setting of a near-perfect model. [84]
3.5.3 Prone to adversarial attacks
Adversarial attacks are either targeted or non-targeted inputs uniquely engi-
neered to cause mis-classification and fool an AI model to produce an incorrect 
output. [67] This tendency for adversarial attacks in medical AI applications is due 
to the inherent monetary incentive for fraud in healthcare as an industry with more 
than three trillion-dollar annual expenditure. [68] A second reason is the technical 
vulnerability of the models in healthcare.
3.5.4 Implicit bias propagation
In an ethnically diverse nation like the US, an excellent AI/ML output can only 
be achieved if the training data utilized are equally diverse. If there is no conscious 
effort to ensure diversity of training data, the algorithm would be propagating the 
conscious and subconscious bias that exists in our society. [85] An example is an 
algorithm developed to detect malignant melanoma.
Malignant melanoma is treatable if detected earlier and ML algorithm can aid 
in early detection. However, the algorithm is at risk of bias and disparity already 
grounded in our society due to the lack of adequate representation of people of 
color/darker skin tone in training data. [85] This limitation can hinder the util-
ity of the algorithm for people of color. Presently, most ML programs like the 
International Skin Imaging Collaboration Project source their training dataset 
mostly from fair skinned populations in the US, Australia, and Europe. [85]
Other manifestations of propagated bias include: fit bits® produces inaccurate 
heart rate in people of color [86] and biases and mislabeling of facial recognition 
software with algorithm output of people of Asian descent represented as blinking 
facial images. [69] The risk here is the tendency to worsen all our societal ills like 
health disparity, inequality, gender bias, and racism, which are all hindrances to 
quality public health for all.
3.5.5 Unable to handle outliers/unexpected data points/events without precedence
ML algorithms are only as good as the quality of their training data set. 
Unexpected data points and sudden changes in pre-defined events will likely result 
in poor performance. This lack of initiative of the ML/AI algorithm is coupled with 
a lack of empathy displayed in a human-to human healthcare interaction, repre-
senting a setback for patient satisfaction.
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3.5.6 Lack of consensus on disclosure of AI/ML tools in direct patient care
There exists a lot of ethical dilemmas in the application of ML tools which 
cannot be ignored. One of the dilemmas we face is the need for disclosure whenever 
ML tools are used in direct patient care. [87] In most of these applications, patients 
are not aware that the care from their clinician is augmented by ML algorithms even 
when the effectiveness of these algorithms are yet to be proven. [70] There is still no 
consensus amongst providers and patients alike regarding the right ethical approach 
to tackle this issue.
4.  Separating the “wheat from the chaff:” evaluating and monitoring of 
HIT and DH tools for value and healthcare quality
Evaluation of DH tool/intervention is the objective and systemic assessment 
of a DH intervention/tool with the sole purpose of determining the efficacy, 
efficiency, impact, sustainability, and extent to which pre-set specific objectives 
are met. According to the World Health Organization, “evaluation asks whether 
the DH tool/project is doing the right things, while monitoring asks whether the 
DH tool/project is doing things right.” [88] Although monitoring and evaluation 
(M&E) are distinct entities, they are usually addressed simultaneously from pre-
prototype/prototype stage through the pilot and demonstration/display of tool up 
to the stage of scale up.
4.1 Stages of monitoring and evaluation
The first stage of M&E is to identify the stage of maturity of the tool. This 
determination will play into the methodology/framework utilized for M&E.
After identifying the stage of maturity of tool, the next step would be to ascer-
tain concrete baseline expectations of the tool and define appropriate claims based 
on stage of maturity of the DH tool. The usability of the tool is an important mea-
sure that should be evaluated in all the stages of maturity from early to late stages. It 
is also important to set expectations in relation to time to deliverables to guide M&E 
activities. A tool being developed to shorten wait time at the clinic should get input 
from patients about their pain points while setting M&E standards.
The next steps is to define the M&E framework to guide the process. There are 
well-established frameworks for M&E published in the literature; however, I favor 
structures that are result oriented. [73, 88] To strengthen the evaluation framework, 
it should be developed through a stakeholder consultative process and reviewed as 
needed during the life cycle of the project.
The next step is to determine who will be carrying out these M&E activities, 
how many resources will be required, and the time-based deliverables expected 
from the team in charge.
5.  Navigating the challenges of HIT and DH for quality improvement: a 
call to action for all stakeholders
Considering the degree of rapid transformation and dynamism we are experi-
encing with the 4th Industrial Revolution, only organizations positioned to adapt 
will succeed. This adaptation requires that all stakeholders learn new skill sets as we 
navigate this transformation.
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5.1 Stakeholder specific suggestions to navigate 4th industrial revolution
5.1.1 Government and regulatory agencies
Government regulatory oversight teams are needed to craft rules/policies to 
regulate broad DH principles like security, privacy/disclosures of DH tools, fair-
ness and equity of implementation, and avoidance of bias in implementation. The 
regulatory rigors placed before approval of DH tools should be based on the level of 
risk of a DH tool in the event of failure, determined by a baseline failure mode and 
effect analysis.
Government mandates should ensure that DH tools maintain a well laid out 
process for human oversight of implementation no matter how “perfect” the 
tool may be.
5.1.2 Professional expert organizations
Professional organizations can assist with navigating complexities as it relates to 
specific requirements for M&E of DH tools developed for their subsections. Once 
general overall policies are established by the government or regulatory agencies 
to address fundamental societal issues to ensure quality and safety of DH, expert 
organizations can help narrow down these policies to suit their subsection of the 
healthcare ecosystem.
5.1.3 Payers
Payers are responsible for processing patient eligibility, enrollment, claims, and 
payment of healthcare services. In the US, payers exists as either governmental 
(Medicare/Medicaid) or private entities. A testament to the fragmented nature of 
the US healthcare system is the fact it has more than 900 healthcare payers as of 
2020. [89] These entities have a significant influence on how healthcare is delivered 
in the US based on their reimbursement schemes. As part of their basis for reim-
bursement of any healthcare service which has been augmented by DH, they should 
mandate standardized M&E of the tools to justify compensation; it is equally 
important to be wary of mandates that would stifle innovation.
5.1.4 Vendors
Healthcare vendors ranging from device and pharmaceutical manufacturers to 
core HIT and analytics developers and entrepreneurs are numerous; in fact, there 
are more than 370 HIT-specific vendors in the US as of 2020. [90] Vendors also 
have a role to play in ensuring that DH tools do not only offer novelty but also have 
an in-built yardstick for evaluating their comparative effectiveness for objective 
assessment of their overall impact upon implementation.
5.1.5 Direct patient care organizations
Considering that these centers are the avenue for implementation of most DH 
tools, they must insist on implementing DH tools with a track record of adding 
value to patient safety and improving healthcare quality. In the event the DH tool 
intended for use is novel with no track record, the organization should demand a 
concrete basis and claims for M&E. This will assist with an objective comparison of 
the impact of a new tool with the status quo.
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5.1.6 Healthcare providers
Healthcare providers are often laggards and usually conservative in the adoption 
of new tools, as consequences of failure are very high with regards to patient safety. 
[91] Nevertheless, the 4th Industrial Revolution permeates all sectors of healthcare 
and healthcare providers are directly impacted. They must actively learn how to 
become an information specialist and ask the right questions about a potential DH 
tool to be implemented. [92] Considering that they will be utilizing these tools to 
make important decisions about patients and their safety, it is important they are 
well equipped with the knowledge of how to evaluate and monitor the DH tools for 
optimal healthcare quality.
5.1.7 Patients and caregivers
Patients and caregivers are the ultimate intended beneficiaries of DH tools, 
as any failure of DH tool implemented will have an adverse consequence on their 
safety and quality of health. [93] In this new dispensation, they must prompt their 
healthcare providers to ask the right questions from the DH tools’ developers. 
Patients and caregivers should understand that, as we progress further into the 
4th Industrial Revolution, these DH tools will increasingly play an essential role in 
decisions about their care directly or indirectly.
6. Conclusion
The quadruple aim describes healthcare value as improved health outcomes, 
increase patient satisfaction, reduced costs, and healthcare provider satisfaction/
fulfillment. DH tools have shown potential in improving healthcare quality and 
achieving the quadruple aim, such as promoting behaviors like healthy eating and 
smoking cessation, improving outcome in people with chronic conditions like 
cardiovascular diseases, and increasing health access through telemedicine and 
remote monitoring. [72, 94]
Although there are demonstrated impact of DH tools in healthcare quality, it is 
still not an overall fix able to transition us from our state of sick care to optimum 
healthcare quality alone. Its applications and implementation are filled with many 
limitations presently hindering the achievement of its full potential in healthcare 
quality improvement. We cannot figure out how effective a tool is without a pre-
defined basis on how to ascertain its effectiveness. Presently the evaluation and per-
formance measurement in healthcare is costly, redundant, and labyrinthine. [78]
DH tools are only part of the solution and not an ultimate solution. As such 
every DH tool implementation should be considered in the context of the overall 
socio-technical ecosystem. All innovations should be based on stakeholders’ input 
right from the start of conception. No matter how effective a piece of technology is, 
if it is implemented in a poorly optimized system, it will likely result in failure.
Navigating the 4th Industrial Revolution requires that all stakeholders play 
an active role in this transition. No doubt it brings forth many possibilities for 
healthcare quality improvement; however, in the absence of evaluation standards 
and a systematic approach to its implementation, we risk being immersed in hype 
born out of the hope of an elusive better outcome. DH tools are key components 
in achieving value in healthcare, but it is not the destination and neither is it the 
goal, but rather a catalyst in the process of obtaining the ultimate goal of the 
quadruple aim.
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HIT Health Information Technology
IoMT Internet of Medical Things
HITECH Health Information Technology for Economic and Clinical Health
ML Machine learning
AI Artificial Intelligence
DMAIC Design, Measure, Analyze, Improve, and Control
GDP Gross Domestic Product
HER Electronic Health Record
HRRP Medicare’s Hospital Readmissions Reduction Program
CDS Clinical Decision Support
FDA Food and Drug Administration
M&E Monitoring and Evaluation
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